invivodata First to Implement Palm TX Handhelds in Clinical Trials, Letting Patients Securely Log Data from Wireless Locations Worldwide

SUNNYVALE, Calif., Apr 25, 2006 (BUSINESS WIRE) — Palm, Inc. (Nasdaq:PALM) and invivodata(R) Inc., are helping clinical-trial sponsors capture more reliable Patient Reported Outcomes (PRO) data and reduce drug-development costs by giving patients better tools for sharing information about their experiences during clinical trials. invivodata, a leader in electronic Patient Reported Outcomes (ePRO) solutions for global clinical research, has standardized on the Palm(R) TX handheld, coupled with invivodata’s wireless modem cradle, for use in clinical trials. The global wireless ePRO solution, available only from invivodata, already is being used by more than 600 patients in two clinical trials across Europe and North America.

With DiaryPRO(R), invivodata’s market-leading global ePRO solution, clinical-trial sponsors can collect PRO data more reliably and efficiently from anywhere in the world where wireless access is available. Patients also benefit from the Palm TX handheld’s larger, higher-resolution, 320×480 color screen, which is easy to read and allows for more comprehensive assessments than most handheld screens on the market.

“Clinical trials are an essential step in bringing important life-saving drugs to market. With the improvements in reliability and accuracy of PRO data delivered by invivodata, pharmaceutical and medical device companies can gain competitive advantage and bring a drug to market more efficiently,” said Tara Griffin, vice president of enterprise markets, Palm, Inc. “invivodata’s ePRO solution, based on the Palm TX handheld, is very patient-friendly, delivering a superior mobile experience for trial participants and valuable data for investigators.”

When conducting worldwide clinical trials, most sponsors patch together a mix of wired and unwired electronic diary (eDiary) devices that vary in screen size, functionality, cost, development and reliability. Such solutions can be expensive because they require multiple versions of hardware, software, and training and help-desk materials. Additionally, trial sponsors may have to modify questionnaires to fit varying kinds of eDiary screens, which would require the sponsor to demonstrate that patients interpret the questions uniformly, in order to reduce regulatory risk.

“With the Palm TX handheld and our wireless modem cradle, our clients can benefit from more reliable and valid PRO data, without the worry of costly inconsistencies among multiple eDiary devices,” said Doug Engfer, founder, president and chief executive officer of invivodata. “The solution is also well-suited for patients. Elderly patients in particular appreciate the larger screen size, easy-to-use interface and ample battery life, making the Palm TX a superior choice.”

A 312MHz processor gives patients the ability to enter large volumes of highly detailed data without losing speed or power. The Palm TX handheld’s 128MB flash memory helps protect data, and the screen rotates for portrait or landscape viewing. Wireless technology provides patients with functionality to upload clinical trial data automatically and seamlessly, and built-in Bluetooth(R) technology supports invivodata’s SyncPro(TM) architecture to allow integration with physiological data monitors, measuring such factors as blood-glucose levels or respiratory peak-flow volumes.(1)

The Palm TX handheld has an estimated U.S. street price of $299 and is available now from the Palm online store (http://store.palm.com), at Palm Retail Stores and at select retailers and resellers throughout the world.

More information about Palm healthcare solutions is available at www.palm.com/healthcare or by calling 1-888-223-4817.

Palm - About Palm, Inc. - Investor Relations - Press Release.